LP-019 Social maladjustment and anxiety-depressive spectrum disorders in system lupus erythematosus and primary antiphospholipid syndrome patients

LP-019 Social maladjustment and anxiety-depressive spectrum disorders in system lupus erythematosus and primary antiphospholipid syndrome patients

Bibliographic Details
Main Authors:	Tatiana Reshetnyak, Fariza Cheldieva, Anastasia Borisova, Olga Seravina, Oksana Kovalevskaya, Yuriy Veltishchev, Tatyana Lisitsyna, Anton Abramkin, Artur Zeltyn
Format:	Article
Language:	English
Published:	BMJ Publishing Group 2023-07-01
Series:	Lupus Science and Medicine

Similar Items

Mental disorders in antiphospholipid syndrome patients: association with clinical and immunological manifestations of the disease
by: А. В. Borisova, et al.
Published: (2024-04-01)

Mental disorders and cognitive impairment in patients with antiphospholipid syndrome
by: A. B. Borisova, et al.
Published: (2020-06-01)

Extra criterial antiphospholipid antibodies in patients with antiphospholipid syndrome and systemic lupus erythematosus (preliminary data)
by: F. A. Cheldieva, et al.
Published: (2021-10-01)

Anxiety-depressive spectrum disorders in patients with obstetric antiphospholipid syndrome
by: A. B. Borisova, et al.
Published: (2024-12-01)

PO.2.43 The activity and damage index in systemic lupus erythematosus depending on antiphospholipid antibodies
by: T Reshetnyak, et al.
Published: (2022-10-01)

Mental disorders in patients with systemic lupus erythematosus: association with activity and the course of rheumatic disease
by: Anastasia B. Borisova, et al.
Published: (2023-07-01)

ANTIPHOSPHOLIPID SYNDROME AND SYSTEMIC LUPUS ERYTHEMATOSUS: WHAT DISEASE IS A CAUSE OF ORGAN DAMAGES?
by: F. A. Cheldieva, et al.
Published: (2020-04-01)

Global antiphospholipid syndrome score (GAPSS) in patients with systemic lupus erythematosus
by: F. A. Cheldieva, et al.
Published: (2022-11-01)

Difficulties in management of patients with systemic lupus erythematosus and antiphospholipid syndrome in combination with melanoma and infiltrative tuberculosis (clinical observations)
by: A. A. Shumilova, et al.
Published: (2021-08-01)

Antiphospholipide antibodies subtypes in systemic lupus erythematosus and antiphospholipid syndrome
by: T M Reshetnyak, et al.
Published: (2005-10-01)

LP-001 Antiphospholipid syndrome in juvenile systemic lupus erythematosus: the Malaysian experience
by: La Reina Sangaran, et al.
Published: (2023-07-01)

Efficacy and safety of long-term use of low molecular weight heparins in patients with systemic lupus erythematosus and antiphospholipid syndrome
by: N. V. Seredavkina, et al.
Published: (2023-10-01)

THE IMPACT OF ADEQUATE PSYCHOPHARMACOTHERAPY ON THE EFFICIENCY OF TREATMENT IN PATIENTS WITH RHEUMATOID ARTHRITIS
by: A. A. Abramkin, et al.
Published: (2018-05-01)

EFFECTS OF SYNTHETIC DISEASE-MODIFYING ANTIRHEUMATIC DRUGS, BIOLOGICAL AGENTS, AND PSYCHOPHARMACOTHERAPY ON THE MENTAL DISORDERS IN PATIENTS WITH RHEUMATOID ARTHRITIS
by: A. A. Abramkin, et al.
Published: (2017-09-01)

Chronic pain and depression in patients with rheumatoid arthritis: results of five - year follow - up
by: T A Lisitsyna, et al.
Published: (2019-05-01)

Antibodies to domain I β2 -glycoprotein 1 in patients with antiphospholipid syndrome and systemic lupus erythematosus
by: F. A. Cheldieva, et al.
Published: (2022-07-01)

Netosis in the pathogenesis of antiphospholipid syndrome and systemic lupus erythematosus
by: K. S. Nurbaeva, et al.
Published: (2021-10-01)

Aminoquinoline drugs in the treatment of systemic lupus erythematosus and antiphospholipid syndrome
by: L V Kondratyeva, et al.
Published: (2008-08-01)

Successful psychopharmacotherapy of anxiety and depressive disorders improve functional limitations in patients with rheumatoid arthritis
by: Anton A. Abramkin, et al.
Published: (2022-06-01)

Influence of successful psychopharmacotherapy of anxiety-depressive spectrum disorders on the severity of chronic fatigue in patients with rheumatoid arthritis
by: Anton A. Abramkin, et al.
Published: (2021-05-01)

Variants of psychiatric disorders in patients with systemic lupus erythematosus
by: T A Lisitsyna, et al.
Published: (2008-08-01)

FACTORS INFLUENCING THE EFFICIENCY OF THERAPY IN PATIENTS WITH RHEUMATOID ARTHRITIS: THE ROLE OF COMORBID MENTAL AND SOMATIC DISEASES
by: A. A. Abramkin, et al.
Published: (2018-09-01)

Cognitive impairments in patients with rheumatoid arthritis and comorbid anxiety and depressive disorders: Outcomes of the five-years prospective study
by: A. A. Abramkin, et al.
Published: (2024-11-01)

Depression and severity of articular destruction in patients with rheumatoid arthritis
by: A. A. Abramkin, et al.
Published: (2020-06-01)

Efficacy of olokizumab against comorbid depressive disorder in patients with rheumatoid arthritis: Preliminary results of the study
by: T. A. Lisitsyna, et al.
Published: (2023-04-01)

Blood nitrates content in patients with systemic lupus erythematosus and antiphospholipid syndrome
by: D V Reshetnyak, et al.
Published: (2004-05-01)

Antibodies to the phosphatidylserine/prothrombin complex in the diagnosis of antiphospholipid syndrome
by: Tatiana M. Reshetnyak, et al.
Published: (2022-06-01)

Assessment of the activity and organ damage in antiphospholipid syndrome
by: F. A. Cheldieva, et al.
Published: (2021-08-01)

Systemic lupus erythematosus and antiphospholipid syndrome: past, present, future
by: Evgeny L. Nasonov, et al.
Published: (2023-07-01)

NARUShENIYa SNA U BOL'NYKh REVMATOIDNYM ARTRITOM I SISTEMNOY KRASNOY VOLChANKOY: EFFEKTIVNOST' I BEZOPASNOST' PREPARATA ZOLPIDEM (SANVAL)
by: Tatyana Andreyevna Lisitsyna, et al.
Published: (2010-10-01)

Adaptation of the Russian version of the activity index of systemic lupus erythematosus EASY-BILAG
by: A. A. Shumilova, et al.
Published: (2023-10-01)

Thrombotic antiphospholipid syndrome: Recurrent thromboses
by: Tatiana M. Reshetnyak, et al.
Published: (2024-09-01)

Citrullinated histone H3 in systemic lupus erythematosus and antiphospholipid syndrome (preliminary results)
by: K. S. Nurbaeva, et al.
Published: (2023-08-01)

Von Willebrand factor antigen in systemic lupus erythematosus and antiphospholipid syndrome
by: A A Novikov, et al.
Published: (2004-08-01)

Risk factors and recurrent thrombosis in primary antiphospholipid syndrome
by: Fariza A. Cheldieva, et al.
Published: (2023-10-01)

Proinflammatory cytokines and depression in rheumatoid arthritis
by: Tatyana Andreyevna Lisitsyna, et al.
Published: (2013-06-01)

Global Antiphospholipid Syndrome Score (GAPSS) in patients with primary antiphospholipid syndrome
by: F. A. Cheldieva, et al.
Published: (2023-02-01)

Editorial: Systemic Lupus Erythematosus and Antiphospholipid Syndrome
by: Pier Luigi Meroni, et al.
Published: (2019-02-01)

Chronic stress and mental disorders in patients with systemic scleroderma: Results of an interdisciplinary study
by: O F Seravina, et al.
Published: (2017-05-01)

Thromboembolic complications in antiphospholipid syndrome and ankylosing spondylitis (two clinical cases)
by: K. S. Nurbaeva, et al.
Published: (2021-02-01)